LINDA COLLINS: Open Payments
NPI 1932381464 · OAKWOOD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$484 in 15 payments from 8 companies in 2025. Trend: 2023 $201 · 2024 $678 · 2025 $484
Food & beverage: $484
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $167 |
| SOBI, INC | 1 | $117 |
| ABBVIE INC. | 3 | $53 |
| Boston Scientific Corporation | 1 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Janssen Biotech, Inc. | 1 | $15 |
Products named: Ozempic, VRAYLAR, WaveWriter Alpha Prime 16, Kerendia, AIRSUPRA, XIFAXAN, TREMFYA.
Industry payments across GA — which companies pay providers there.
